摘要
目的通过临床资料分析,探讨妇女绝经期功血伴中度贫血患者诊治的方法和疗效。方法选择妇科门诊绝经过渡期功血伴中度贫血患者65例,分三组,分别为口服米非司酮组;口服安宫黄体酮组;口服妈富隆组。治疗前均行诊断性刮宫,病理结果为子宫内膜单纯型增生,而复杂型增生不采用此法。结果米非司酮组、妈富隆组较安宫黄体酮组能较有效地帮助患者度过出血期并使贫血改善,安宫黄体酮组由于其撤药后出血量较多,不利于贫血的改善。结论绝经过渡期功血伴中度贫血患者,可采用非米司酮或妈富隆治疗。
Objective To analyze the clinical data, so that both the methods and the efficacy of curing functional uterine hemorrhage and medium anemia of women in their menopausal transition period can be studied. Methods 65 eases with functional uterine hemorhage and medium anemia in their menopausal transition were chosen randomly from the gynecological clinic and were divided into 3 groups. The first group took mifepristone orally; the second group took medroxyprogesterone acetate orally; the third group took Marvelon orally. Before the treatment, the diagnostic uterine curettage were performed to see whether the pathologic result is the pute hyperplasia of the endometrium or not. If it is the complicated hyperplasia, the treatment will not be adopted. Results The patients which had taken mifepristone and marvelon attained better therapeutic effect. The patients which had taken the medroxyprogesterone acetate were not beneficial from the treatment because the magnitude of their hemorrhage became too much after they stopped taking the medicine. Conclusion The patients with functional uterine hemorrhage and medium anemia in their menopausal transition period can be treated by taking mifepristone or marvelon.
出处
《中国煤炭工业医学杂志》
2008年第9期1311-1312,共2页
Chinese Journal of Coal Industry Medicine
关键词
绝经过渡期
功血
贫血
米非司酮
妈富隆
安宫黄体酮
menopausal transition
functional uterine hemorrhage
anaemia
mifepristone
Marvelon
medroxyprogesterone
